Effectiveness of the oral polio vaccine and prospects for global eradication of polio

Tropical Doctor

Volumn 37, Issue 2, 2007, Pages 125-126

  Wiysonge, C S ^a,b   Nomo, E ^a   Ticha, J M ^c   Shang, J D ^d   Njamnshi, A K ^d   Shey, M S ^b  

^a MINISTRY OF PUBLIC HEALTH   (Cameroon)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WHO Country Office   (India)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

CHILD; ENDEMIC DISEASE; FLACCID PARALYSIS; HUMAN; LETTER; MASS IMMUNIZATION; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PROSPECTIVE STUDY; TROPICS; CAMEROON; HEALTH; HEALTH PROMOTION;

CAMEROON; HEALTH PROMOTION; HUMANS; MASS IMMUNIZATION; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; WORLD HEALTH;

EID: 34447342277     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/004947507780609301     Document Type: Letter

References (5)

1. World Health Organization. Global polio eradication initiative strategic plan 2004-2008. Wkly Epidemiol Rec 2004;79:55-57
2. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991;13:926-939
3. Sutter RW, Cochi SL, Melnick JL. Live attenuated poliovirus vaccines. In: Plotkin S, Oreinstein W, eds. Vaccines. 3rd edn. Philadelphia: Saunders, 1999: 364-408
4. Sutter RW, Patriarca PA, Suleiman AJ, et al. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 1993;22:936-944
5. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-1068